Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-053980

Chief Commercial Officer bought 3,100 shares at $11.53 ($35,743)

From the SEC's structured data for this filing

Trades in this filing

Wettig Thane · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-26 Purchase : show line 1 in the form +3,100 $11.53 $35,743 48,816 D
Open-market purchases · 3,100 sh · avg $11.53 · $35,743
Loading xslF345X03/doc4.xml…